Antibiotics resistance solution to be commercialised
By Richard Schoonraad | Bacteria, Cardiovascular Science and Diabetes Program, Emergency Medicine, Kidney Disease, Media Releases, News & Events, Synthetic Biology and Drug Discovery, Targeted Drug Delivery, TranslationBreakthrough diagnostic technology to be commercialised in Australia in race to save millions globally from antibiotic resistant sepsis. CUREator funds Western Australian research team to develop life-saving technology through the…
Science experiments go bush
By Richard Schoonraad | BioDiscovery, Community, Media Releases, News & EventsJigalong Remote Community School students, living on the edge of the Great Sandy Desert on the western side of the Rabbit Proof Fence, were last week introduced to the world…

Further mysteries of cardiovascular disease-causing plaque revealed
By Richard Schoonraad | Blood Vessels, Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Heart, Media Releases, News & Events, ResearchNew discoveries on where plaque can form and what can trigger a heart attack. Researchers from the Harry Perkins Institute of Medical Research have published new findings that turn the…
Perth MedTech firm secures funding for cannula innovation
By Richard Schoonraad | Bioimaging Research and Innovation for Translational Engingeering BRITE, Funding, Imaging and Therapy, Media Releases, News & EventsVeinTech awarded $493,489 of Accelerating Commercialisation funding Perth based medical device company VeinTech is excited to announce it has secured $493,489 of matched non-dilutive funding to continue its efforts to…
$5m funding awarded to researchers for inherited disease hunt
By Richard Schoonraad | Funding, Genes, Genetic Disease, Genetic Disease, Genetics, Media Releases, News & Events, Other Genetic Disorders, ResearchNational approach to finding the causes of several debilitating diseases Medical Research Future Fund awards $4,877,532 over 5 years to ‘The missing heritability of human disease: discovery to implementation’. Blood…
New liver cancer blood test gets $2.5m research funding boost
By Richard Schoonraad | Bioimaging Research and Innovation for Translational Engingeering BRITE, Cancer, Cancer, Cancer Epigenetics, Cell Signalling, Cell-To-Cell Communication, Functional Genomics, Genes, Media Releases, News & Events, Single CellPredicting relapse for one of the world's deadliest cancers. Perth cancer researchers are on track to improve the outcomes of patients with the most common type of primary liver cancer.…
ACRF Centre for Advanced Cancer Genomics opens in Perth
By Richard Schoonraad | Bioimaging Research and Innovation for Translational Engingeering BRITE, Cancer, Cancer, Cancer Epigenetics, Cell Signalling, Cell-To-Cell Communication, Functional Genomics, Genes, Media Releases, News & Events, Single CellLatest technology analyses WA cancer patient tumours. The Australian Cancer Research Foundation (ACRF) Centre for Advanced Cancer Genomics, housing the next generation DNA sequencing technology, was opened today at the…
Connecting scientists and donors a winning mix
By Richard Schoonraad | awards, Community Events, Fundraising, Inspiration, Media Releases, News & Events, Perkins EventsHarry Perkins Institute wins 2023 Fundraising Team of the Year In the midst of the Golden Globes and the Oscars season, a small team in Perth who support medical research…